U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
146071146071A Study to Evaluate the Safety of D-TRANS Fentanyl With Naltrexone in Adult Patients With Chronic Pain and Who Are Opioid TolerantCompletedNo Results AvailableChronic PainDrug: fentanyl; naltrexonehttps://ClinicalTrials.gov/show/NCT00650182
146072146072Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mgCompletedNo Results AvailableHealthyDrug: Clopidogrel Bisulfate Tablets 75 mg|Drug: Plavix® Tablets 75 mghttps://ClinicalTrials.gov/show/NCT00650169
146073146073Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisBiological: adalimumab|Biological: adalimumabhttps://ClinicalTrials.gov/show/NCT00650156
146074146074Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial InfarctionRecruitingNo Results AvailableAcute Myocardial InfarctionDrug: Lenograstim (GRANOCYTE)=GCSF|Drug: Sitagliptin (Januvia)|Drug: Sodium Chloride (NaCl) 0.9 %|Drug: Gelatinhttps://ClinicalTrials.gov/show/NCT00650143
146075146075Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and MedicinesCompletedNo Results AvailableDriving Under the Influencehttps://ClinicalTrials.gov/show/NCT00650130
146076146076Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal SystemCompletedNo Results AvailableHealthyDrug: Mylan Fentanyl Transdermal System 25 mcg/h + Scotch Duct Tape (3M)|Drug: Duragesic 25 mcg/h + Scotch Duct Tape (3M)|Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M)|Drug: Duragesic 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M)|Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Microfoam Tape (3M)|Drug: Duragesic 25 mcg/h + Microfoam Tape (3M)https://ClinicalTrials.gov/show/NCT00650117
146077146077Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164CompletedHas ResultsParkinson DiseaseDrug: Ropinirole XL (formerly CR)https://ClinicalTrials.gov/show/NCT00650104
146078146078Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPFCompletedHas ResultsPulmonary FibrosisDrug: N-acetylcysteine (NAC)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00650091
146079146079Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid ArthritisCompletedHas ResultsRheumatoid ArthritisDrug: MR prednisone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00650078
146080146080Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mgCompletedNo Results AvailableHealthyDrug: Cetirizine HCl Tablets 10 mg|Drug: Zyrtec® Tablets 10 mghttps://ClinicalTrials.gov/show/NCT00650065
146081146081Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mgCompletedNo Results AvailableHealthyDrug: Zonisamide Capsules 100 mg|Drug: Zonegran® Capsules 100 mghttps://ClinicalTrials.gov/show/NCT00650052
146082146082Double-Blind, Randomized Study Of The Analgesic Efficacy And Safety Of Valdecoxib 20 Mg Daily And Valdecoxib 20 Mg Twice Daily Compared To Placebo For Management Of Acute Postsurgical Pain In Anterior Cruciate Ligament (ACL) ReconstructionCompletedNo Results AvailablePainDrug: placebo|Drug: valdecoxib|Drug: valdecoxibhttps://ClinicalTrials.gov/show/NCT00650039
146083146083Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid ArthritisApproved for marketingNo Results AvailableRheumatoid ArthritisBiological: adalimumabhttps://ClinicalTrials.gov/show/NCT00650026
146084146084Fed Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mgCompletedNo Results AvailableHealthyDrug: Midodrine HCl Tablets 5 mg|Drug: ProAmatine® Tablets 5 mghttps://ClinicalTrials.gov/show/NCT00650013
146085146085Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mgCompletedNo Results AvailableHealthyDrug: Modafinil Tablets 200 mg|Drug: Provigil® Tablets 200 mghttps://ClinicalTrials.gov/show/NCT00650000
146086146086Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mgCompletedNo Results AvailableHealthyDrug: Albuterol Sulfate Extended-Release Tablets 8 mg|Drug: VoSpire® ER Tablets 8 mghttps://ClinicalTrials.gov/show/NCT00649987
146087146087Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mgCompletedNo Results AvailableHealthyDrug: Valacyclovir Hydrochloride Tablets 1000 mg|Drug: Valtrex® Tablets 1000 mghttps://ClinicalTrials.gov/show/NCT00649974
146088146088Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage StudyCompletedHas ResultsPremature Birth|Brain InjuryDrug: Melatonin injectionhttps://ClinicalTrials.gov/show/NCT00649961
146089146089Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mgCompletedNo Results AvailableHealthyDrug: Metformin Hydrochloride ER Tablets 500 mg|Drug: Glucophage XR 500 mghttps://ClinicalTrials.gov/show/NCT00649948
146090146090Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mgCompletedNo Results AvailableHealthyDrug: Azithromycin Tablets 600 mg|Drug: Zithromax® Tablets 600 mghttps://ClinicalTrials.gov/show/NCT00649935
146091146091Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisBiological: adalimumab|Biological: placebo|Biological: adalimumabhttps://ClinicalTrials.gov/show/NCT00649922
146092146092Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic PatientsRecruitingNo Results AvailableDiabetes Mellitus, Type IIhttps://ClinicalTrials.gov/show/NCT00649909
146093146093Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/DayCompletedNo Results AvailableHealthyDrug: Mylan Estradiol Transdermal System 0.025 mg/day|Drug: Climara® Transdermal System 0.025 mg/dayhttps://ClinicalTrials.gov/show/NCT00649896
146094146094Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to - CompletedNo Results AvailableInfluenzaBiological: Influenza Trivalent Inactivated vaccines Novartis|Biological: Influenza Trivalent Inactivated vaccineshttps://ClinicalTrials.gov/show/NCT00649883
146095146095Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mgCompletedNo Results AvailableHealthyDrug: Valacyclovir Hydrochloride Tablets 1000 mg|Drug: Valtrex® Tablets 1000 mghttps://ClinicalTrials.gov/show/NCT00649870
146096146096Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mgCompletedNo Results AvailableHealthyDrug: Cetirizine HCl Tablets 10 mg|Drug: Zyrtec® 10 mghttps://ClinicalTrials.gov/show/NCT00649857
146097146097A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic DrugsCompletedNo Results AvailableSchizophreniaDrug: Clozapine|Drug: Ziprasidonehttps://ClinicalTrials.gov/show/NCT00649844
146098146098A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic BronchitisCompletedNo Results AvailableBronchitis, ChronicDrug: Amoxicillin/clavulinic acid|Drug: Azithromycinhttps://ClinicalTrials.gov/show/NCT00649831
146099146099Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mgCompletedNo Results AvailableHealthyDrug: Lorazepam Tablets 2 mg|Drug: Ativan Tablets 2 mghttps://ClinicalTrials.gov/show/NCT00649818
146100146100Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mgCompletedNo Results AvailableHealthyDrug: Verapamil Hydrochloride Extended-Release Capsules, 300 mg|Drug: Verelan® PM Extended-Release Capsules, 300 mghttps://ClinicalTrials.gov/show/NCT00649805

* Görseller ve İçerik tekif hakkına sahip olabilir